NLRP3 and polycystic ovary syndrome: Overall, NLRP3 mRNA levels in SAT and VAT combined were not significantly different between the PCOS group (number of biopsies = 15) and the non-PCOS group (number of biopsies = 16) (median [IQR], 1.080 [0.04714–2.360] vs. 1.761 [1.374–2.305], p = 0.219, respectively).